Showing results (201-210 of 235) with videos related to
Sort By:
Pageof 24
The New England Journal of Medicine|August 28, 2014
Cardiovascular risk and events in 17 low-, middle-, and high-income countriesSalim Yusuf, Sumathy Rangarajan, Koon Teo, et al.Lancet (London, England)|May 24, 2020
Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort studyMarjan Walli-Attaei, Philip Joseph, Annika Rosengren, et al.Cardiovascular Research|August 11, 2020
Global variations in the prevalence, treatment, and impact of atrial fibrillation in a multi-national cohort of 153 152 middle-aged individualsPhilip G Joseph, Jeffrey S Healey, Parminder Raina, et al.Journal of Hypertension|March 24, 2026
2026 Latin American consensus for the management of patients with hypertension and cardio-renal and metabolic disturbances: endorsed by the Latin American Society of Hypertension, the Iberoamerican Hypertension League, and the World Hypertension LeagueAntonio Coca, Ramiro Sánchez, Dora I Molina de Salazar, et al.The Lancet. Global Health|January 22, 2022
Variations in risks from smoking between high-income, middle-income, and low-income countries: an analysis of data from 179 000 participants from 63 countriesThirunavukkarasu Sathish, Koon K Teo, Philip Britz-McKibbin, et al.BMJ Open Diabetes Research & Care|May 20, 2020
Association of dairy consumption with metabolic syndrome, hypertension and diabetes in 147 812 individuals from 21 countriesBalaji Bhavadharini, Mahshid Dehghan, Andrew Mente, et al.Lancet (London, England)|September 16, 2018
Association of dairy intake with cardiovascular disease and mortality in 21 countries from five continents (PURE): a prospective cohort studyMahshid Dehghan, Andrew Mente, Sumathy Rangarajan, et al.Lancet (London, England)|September 8, 2019
Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort studySalim Yusuf, Philip Joseph, Sumathy Rangarajan, et al.The Lancet. Diabetes & Endocrinology|September 2, 2018
Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological studyClara K Chow, Chinthanie Ramasundarahettige, Weihong Hu, et al.Journal of the American College of Cardiology|April 22, 2026
Heart Failure Among 173,000 Community-Dwelling Participants From 25 Low-, Middle-, and High-Income Countries in the PURE StudyIsabelle Johansson Bartolini, Philip Joseph, Shofiqul Islam, et al.Pageof 24